Viewing Study NCT04511650

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 4:55 PM

Ignite Modification Date: 2025-12-24 @ 4:55 PM

Study NCT ID: NCT04511650

Status: TERMINATED

Last Update Posted: 2023-06-08

First Post: 2020-08-07

Is Possible Gene Therapy: False

Has Adverse Events: True

Brief Title: Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Sponsor: EyePoint Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module